Novan Investor Relations Material
Latest events
Q1 2023
Novan
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Novan Inc
Access all reports
Novan Inc. is a biotechnology company specializing in the development of nitric oxide-based therapies for dermatological and infectious diseases. The company’s proprietary NITRICIL platform enables the controlled release of nitric oxide to target specific medical conditions. Novan’s pipeline includes treatments for skin diseases such as acne, atopic dermatitis, and warts, as well as broader applications in antiviral and antimicrobial therapies. The company is headquartered in Durham, North Carolina, and its shares are listed on the NASDAQ.
Latest articles
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
Ticker symbol
NOVN
Country
🇺🇸 United States